Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA.
about
The histone acetyltransferase domains of CREB-binding protein (CBP) and p300/CBP-associated factor are not necessary for cooperativity with the class II transactivatorExpression regulation of major histocompatibility complex class I and class II encoding genesInterferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cellsHistone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formationMHC class II transactivator represses human IL-4 gene transcription by interruption of promoter binding with CBP/p300, STAT6 and NFAT1 via histone hypoacetylationPositive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoterThe heat shock protein 90-CDC37 chaperone complex is required for signaling by types I and II interferonsDimeric RFX proteins contribute to the activity and lineage specificity of the interleukin-5 receptor alpha promoter through activation and repression domains.Antiviral actions of interferonsCIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivationClass II transactivator: mastering the art of major histocompatibility complex expressionA functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-YBasophils function as antigen-presenting cells for an allergen-induced T helper type 2 responseRegulation of major histocompatibility complex class II gene expression in trophoblast cellsNLRC5, at the Heart of Antigen PresentationHepatitis C Virus Inhibits Cell Surface Expression of HLA-DR, Prevents Dendritic Cell Maturation, and Induces Interleukin-10 ProductionThe Nod-like receptor (NLR) family: a tale of similarities and differencesMHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarctionCritical roles of interferon regulatory factor 4 in CD11bhighCD8alpha- dendritic cell developmentMHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?Murine cytomegalovirus paralyzes macrophages by blocking IFN gamma-induced promoter assembly.CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis.Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor betaApical role for BRG1 in cytokine-induced promoter assemblyInterferon-gamma-induced chromatin remodeling at the CIITA locus is BRG1 dependent.Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptorsTissue selectivity of interferon-stimulated gene expression in mice infected with Dam(+) versus Dam(-) Salmonella enterica serovar Typhimurium strainsPhosphorylation of CIITA directs its oligomerization, accumulation and increased activity on MHCII promoters.Dysregulated recruitment of the histone methyltransferase EZH2 to the class II transactivator (CIITA) promoter IV in breast cancer cells.Multiple histone methyl and acetyltransferase complex components bind the HLA-DRA gene.Regulation of major histocompatibility complex class II gene expression, genetic variation and disease.Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV.Immune escape of γ-herpesviruses from adaptive immunityDiagnostic biomarkers are hidden in the infected host's epigenome.The NOD: a signaling module that regulates apoptosis and host defense against pathogens.Genomic mapping of the MHC transactivator CIITA using an integrated ChIP-seq and genetical genomics approach.Relationship between polymorphism of class II transactivator gene promoters and chronic hepatitis B.CIITA rs4774 and rs6498122 polymorphisms are associated with oral lichen planus in Chinese people: a case-control study.Positive regulatory domain I (PRDM1) and IRF8/PU.1 counter-regulate MHC class II transactivator (CIITA) expression during dendritic cell maturation.Common distal elements orchestrate CIITA isoform-specific expression in multiple cell types
P2860
Q22330805-AEADF347-D68E-4F21-8B55-04AE493518BAQ24273365-3338DE60-FA50-4957-ADF7-6DDEA834BC55Q24289002-A67D86D9-DFDD-4464-85D6-5030BD0F14CAQ24289051-BC25BDB9-2C34-4EA5-A9CB-A324759012A8Q24289144-06D62A8D-29A4-4D1F-A267-314A39FCAA57Q24289417-3D62FF3A-8757-4B39-9E78-4B1CEB76A392Q24294462-EAAD9733-034E-46D9-8CDB-8251D9307A4BQ24517594-BD590D29-6143-4A64-879E-868F1DF097C1Q24550676-D852D02D-BA12-4903-B6EB-438E65416403Q24551176-96B99B18-32F5-48A3-9844-577F66C3D4DDQ24552298-522DE588-E7F5-4CF7-A056-A7D786A29DFAQ24554232-05F11473-3BF5-4263-B058-534B1C971C5AQ24613860-B3416CF6-2B8F-4F4B-A443-95A76C93360DQ24793128-BA96A815-F165-4360-B1EE-3063594D3BA3Q26823400-216A48EB-6ACC-4009-9206-B70DA829F56DQ27485530-D3C797B5-C537-4186-889A-CB57D7C8DCB1Q28472636-3E2C8596-DAAC-46D2-A36A-75E0250DF500Q28581447-6AFD255C-6F48-493E-A2B2-C8D7DC2B2C2CQ28591631-C0F2088E-6675-40F6-97DF-9F52483DC529Q28594418-BAD96923-592C-4CC8-B8B1-03CBF435DCD0Q33716874-0ACABC43-A39A-4E3D-BB9B-83963BC5931DQ33832877-4742A123-45F1-447D-AF43-FF5336B68431Q33957154-B6D84E4C-38A4-48D3-BBC2-CDFB029786DEQ34078375-D6F0BF17-3934-4EFE-A6FD-CA1597A17EFAQ34086467-DFEEF73E-3A6B-4AAB-B0D4-0A4C844C3E25Q34104329-1C8D3F9F-1523-4AC2-9580-A495362C900AQ34132837-34FA3198-605F-4D22-92F0-98FB251C51AEQ34150349-1D6E9495-5DD2-410C-9345-89D652E65D60Q34259906-30B4B4D7-90C4-4A84-942C-5AEE5DC449C5Q34304969-67C893D6-263D-419A-BCAC-1AA5D5AFC069Q34330648-55259455-C10F-440A-967B-BBED36901947Q34334683-84E84ADF-5836-4FA1-B210-54BFD4718BFCQ34345549-33F6CBAC-E4C5-46CC-BA83-C85209E720D8Q34360404-95E617B0-FF5A-43B2-A7D1-5D109560ACEFQ34405567-29A0C620-3A1F-46A7-A06A-46548D07F3E2Q34568890-BD48E615-CA6F-48FF-8257-962852791F50Q34604716-0E543947-E025-4941-A214-AC1AC5F3AE66Q34620260-43A99579-8760-473E-9166-F02B5F9D96E2Q34624167-62F430AB-9D71-41A4-85F0-49FBEF6E81F2Q34641823-E92C3BCF-8D2D-46BD-BA96-B82E5A45CAB8
P2860
Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
name
Expression of MHC class II mol ...... s of the transactivator CIITA.
@ast
Expression of MHC class II mol ...... s of the transactivator CIITA.
@en
type
label
Expression of MHC class II mol ...... s of the transactivator CIITA.
@ast
Expression of MHC class II mol ...... s of the transactivator CIITA.
@en
prefLabel
Expression of MHC class II mol ...... s of the transactivator CIITA.
@ast
Expression of MHC class II mol ...... s of the transactivator CIITA.
@en
P2093
P2860
P356
P1433
P1476
Expression of MHC class II mol ...... s of the transactivator CIITA.
@en
P2093
Muhlethaler-Mottet A
P2860
P304
P356
10.1093/EMBOJ/16.10.2851
P407
P577
1997-05-01T00:00:00Z